Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction

International Heart Journal

Volumn 55, Issue 3, 2014, Pages 271-277

  Okamoto, Naoko ^a   Noma, Takahisa ^a   Ishihara, Yasuhiro ^a   Miyauchi, Yuka ^a   Takabatake, Wataru ^a   Oomizu, Souichi ^a   Yamaoka, Genji ^a   Ishizawa, Makoto ^a   Namba, Tsunetatsu ^a   Murakami, Kazushi ^a   Iwado, Yasuyoshi ^a   Ohmori, Koji ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Inflammation

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3;

AGED; ARTICLE; ATHEROSCLEROSIS; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMILUMINESCENCE ENZYME IMMUNOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HUMAN; IMMUNE RESPONSE; ISCHEMIC CARDIOMYOPATHY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MYOCARDITIS; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE;

AGED; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; IMMUNITY, CELLULAR; MALE; PROGNOSIS; STROKE VOLUME; T-LYMPHOCYTES, REGULATORY; VENTRICULAR FUNCTION, LEFT;

EID: 84901496199     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-343     Document Type: Article

References (25)

1. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-12.
2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subject. Circulation 1993; 88: 107-15.
3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50.
4. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C- 8C. (Review)
5. Vaduganathan M, Greene SJ, Gheorghiade M, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013; 18: 835-45.
6. Yndestad A, Holm AM, Müller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. J Immunol 1995; 155: 1151-64.
8. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of immune response. Immunol Rev 2005; 203: 156-64. (Review)
9. Balandina A, Lécart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-41.
10. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76: 10-4. (Review)
11. Schneider-Hohendorf T, Stenner MP, Wiendl H, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-90.
12. Tang TT, Ding YJ, Liao YH, et al. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 2010; 25: 451-8.
13. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12.
14. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7.
15. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5.
16. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622-31.
17. Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nature Immunol 2005; 6: 1069-70.
18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
20. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185-93.
21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90.
22. Hori M, Sasayama S, Kitabatake A, et al; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-30.
23. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7.
24. Anand IS, Latini R, Florea VG, et al; Val-HeFT Investigators. Creactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-34.
25. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.